Biogen Inc. BIIB shares saw a notable uptick Monday afternoon, after the company revealed a new partnership with Delta Flight Products, a subsidiary of Delta Air Lines DAL, to enhance air travel accessibility for passengers with reduced mobility.
What To Know: This collaboration aims to address the needs of approximately 5.5 million wheelchair users in the United States. The initiative will involve engaging with individuals who have rare neuromuscular diseases to understand their travel experiences and identify gaps in current accessibility provisions.
Insights gathered from these interactions will inform the development of innovative solutions, such as a groundbreaking airplane seat prototype that allows passengers to remain in their wheelchairs throughout the flight.
“Cure SMA and the SMA community have been advocating to make air travel safer and more accessible for individuals with disabilities, especially passengers who use a power wheelchair. We are grateful that Biogen and Delta Flight Products will help raise awareness about the experiences of those traveling with reduced mobility and develop possible solutions to help them travel with ease. This is a meaningful step toward allowing a passenger to use their own wheelchair as their airplane seat,” said Kenneth Hobby, President, Cure SMA.
Related Link: Biogen and Delta Flight Products to Collaborate with Advocates and Patients to Inform the Future of Accessible Air Travel
What Else: The first community engagement under this collaboration will take place at Cure SMA’s Annual SMA Conference in Austin, Texas, from June 6-9, 2024. During this event, attendees will have the opportunity to view DFP’s innovative seat design and other advancements aimed at improving the travel experience for those with mobility devices.
BIIB Price Action: Biogen Inc. shares were up by 2.69% at $231.11 according to Benzinga Pro.
See Also: Why Is Boeing Stock Soaring On Monday?
Image from Shutterstock.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.